Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Clinical and Experimental Rheumatology|May 1, 1997
Statistical considerations concerning clinical studies designed to assess DC-ARTsO Della Casa-Alberighi, R Ferrara, E Marubini
Clinical Pharmacology and Therapeutics|June 7, 2012
Physiologically based pharmacokinetic (PBPK) modeling in childrenJ S Barrett, O Della Casa Alberighi, S Läer, et al.
International Journal of Clinical & Laboratory Research|October 24, 2000
Cyclosporine-A plus steroids versus steroids alone in the 12-month treatment of systemic lupus erythematosusF Dammacco, O Della Casa Alberighi, G Ferraccioli, et al.
Journal of Neuroimmunology|June 1, 1988
NK cells in patients with peripheral neuropathy and IgM monoclonal protein reacting with the myelin-associated glycoprotein (MAG)O Della Casa Alberighi, E Nobile Orazio, P Bonara, et al.
British Journal of Rheumatology|September 1, 1996
Is the control of disease progression within our grasp? Review of the GRISAR study. (Gruppo Reumatologi Italiani Studio Artrite Reumatoide)G F Ferraccioli, O Della Casa-Alberighi, E Marubini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 12, 2013
Two-stage phase II study of imatinib mesylate in subjects with refractory or relapsing neuroblastomaL Calafiore, L Amoroso, O Della Casa Alberighi, et al.
Arthritis and Rheumatism|June 1, 1996
Slow progression of joint damage in early rheumatoid arthritis treated with cyclosporin AG Pasero, F Priolo, E Marubini, et al.
Pageof 1